DCP1A expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 2.18310003408106E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.32039999995093E-06 |
Normal-vs-Stage2 |
5.803600E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.957860E-02 |
Stage1-vs-Stage2 |
8.578800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
4.096400E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.132600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.52189999678288E-08 |
Normal-vs-AfricanAmerican |
1.069820E-01 |
Normal-vs-Asian |
1.59061999999155E-05 |
Caucasian-vs-AfricanAmerican |
4.769800E-02 |
Caucasian-vs-Asian |
8.151400E-01 |
AfricanAmerican-vs-Asian |
4.697800E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.976800E-04 |
Normal-vs-Female |
4.4637999996322E-07 |
Male-vs-Female |
6.371600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.228200E-02 |
Normal-vs-Extreme_Weight |
8.47670000000411E-05 |
Normal-vs-Obese |
2.239800E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
5.049600E-01 |
Normal_Weight-vs-Obese |
3.391400E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
6.592800E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.017000E-04 |
Normal-vs-Age(41-60Yrs) |
1.101990E-03 |
Normal-vs-Age(61-80Yrs) |
3.07850000003107E-06 |
Normal-vs-Age(81-100Yrs) |
4.715600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.352400E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.931600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.424000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.094800E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.315000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.455800E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
4.550400E-01 |
Normal-vs-Grade 3 |
3.403000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
8.623600E-01 |
Grade 2-vs-Grade 4 |
4.550400E-01 |
Grade 3-vs-Grade 4 |
3.403000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.21169999986759E-07 |
Normal-vs-N1 |
2.046000E-02 |
N0-vs-N1 |
6.391800E-02 |
|
|